118 related articles for article (PubMed ID: 2252771)
1. Biocompatibility of dialysis membranes is of no importance for objective or subjective symptoms during or after hemodialysis.
Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM
ASAIO Trans; 1990; 36(3):M637-9. PubMed ID: 2252771
[TBL] [Abstract][Full Text] [Related]
2. Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis.
Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM
Artif Organs; 1994 Dec; 18(12):880-7. PubMed ID: 7887824
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte overshoot: a new sign of bioincompatibility in fast hemodialysis.
Kjellstrand P; Jacobson SH; Skröder R; Holmquist B; Boberg U; Lins LE; Okmark P; Kjellstrand CM
ASAIO Trans; 1990; 36(3):M314-6. PubMed ID: 2252687
[TBL] [Abstract][Full Text] [Related]
4. Research on dialyzers with improved biocompatibility.
van der Steen A
Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis urea rebound and membrane biocompatibility: accuracy of Kt/V estimations.
Navarro JF; del Castillo N; Fernández JL; Macía ML; Méndez ML; Chahin J; García-Nieto V; Gallego E; Mora-Fernández C; García J
Artif Organs; 1997 Feb; 21(2):91-5. PubMed ID: 9028489
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of a polyethylene glycol grafted cellulose membrane on thrombogenicity and biocompatibility during hemodialysis.
Akizawa T; Kino K; Kinugasa E; Koshikawa S; Ikada Y; Kishida A; Hatanaka Y; Imamura K
ASAIO Trans; 1990; 36(3):M640-2. PubMed ID: 2252772
[TBL] [Abstract][Full Text] [Related]
8. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.
Akizawa T; Kinugasa E; Koshikawa S
ASAIO Trans; 1991; 37(3):M384-5. PubMed ID: 1751199
[TBL] [Abstract][Full Text] [Related]
9. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
[TBL] [Abstract][Full Text] [Related]
10. Acute renal failure: role of dialysis membrane biocompatibility.
Pascual M; Swinford RD; Tolkoff-Rubin N
Annu Rev Med; 1997; 48():467-76. PubMed ID: 9046977
[TBL] [Abstract][Full Text] [Related]
11. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
Haufe CC; Eismann U; Deppisch RM; Stein G
Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
13. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
Linnenweber S; Lonnemann G
Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
[TBL] [Abstract][Full Text] [Related]
14. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.
Clark WR; Hamburger RJ; Lysaght MJ
Kidney Int; 1999 Dec; 56(6):2005-15. PubMed ID: 10594776
[TBL] [Abstract][Full Text] [Related]
15. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
[TBL] [Abstract][Full Text] [Related]
16. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
[TBL] [Abstract][Full Text] [Related]
17. Generation of leukotriene B4 by hemodialyzer membranes: a novel index of biocompatibility.
Strasser T; Schiffl H
Klin Wochenschr; 1991 Oct; 69(17):808-12. PubMed ID: 1662325
[TBL] [Abstract][Full Text] [Related]
18. The influence of dialysis membrane upon protein catabolic rate.
Lindsay RM; Spanner E; Heidenheim AP; Lindsay S; LeFebvre JM
ASAIO Trans; 1991; 37(3):M134-5. PubMed ID: 1751080
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility of the dialysis membrane.
Takemoto Y; Naganuma T; Yoshimura R
Contrib Nephrol; 2011; 168():139-145. PubMed ID: 20938134
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-related bioincompatibility of hemodialysis: inhibition of oxidative metabolism, degranulation reaction, enzyme release and leukocyte sequestration in the lung.
Kolb G; Fischer W; Müller T; Höffken H; Joseph K; Lange H; Havemann K
Int J Artif Organs; 1989 May; 12(5):294-8. PubMed ID: 2737768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
